Status:

COMPLETED

Confocal Laser Endomicroscopy During TransUrethral Resection for Improving BC Diagnosis and Treatment

Lead Sponsor:

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Conditions:

Bladder Cancer

CLE

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

A prospective monocenter diagnostic accuracy study of Confocal Laser Endomicroscopy (CLE) for Bladder Cancer(BC) to assess two primary objectives: 1. The diagnostic accuracy of flexible probe-based c...

Detailed Description

Rationale: Initial evaluation of gross hematuria consists of White Light Cystoscopy (WLC). Urine cytology combined with contrast imaging of the upper urothelial tract is performed when a bladder tumo...

Eligibility Criteria

Inclusion

  • Display a papillary bladder tumor on cystoscopy.
  • \>18 years of age.
  • Has given written informed consent.

Exclusion

  • Patients with a known allergy to fluorescein.
  • Pregnancy or lactating women.

Key Trial Info

Start Date :

January 6 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

November 12 2021

Estimated Enrollment :

40 Patients enrolled

Trial Details

Trial ID

NCT05273593

Start Date

January 6 2020

End Date

November 12 2021

Last Update

March 10 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Academic Medical Center

Amsterdam, North Holland, Netherlands, 1105AZ

Confocal Laser Endomicroscopy During TransUrethral Resection for Improving BC Diagnosis and Treatment | DecenTrialz